Open AccessBevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland
Author(s) -
Jingxue Zhang,
Xuejing Yan,
Rui Li,
Shen Wu,
Qian Liu,
Jing Li,
Jianmin Ma
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s352623
Subject(s) - adenoid cystic carcinoma , bevacizumab , medicine , lacrimal gland , cancer research , pathology , oncology , carcinoma , chemotherapy